GlaxoSmithKline is also working on an Ebola vaccine.
Pages: 1 2 | Single Page
Topics: AfricaEbolaResearchSierra LeoneVaccine
ACEP Now: November 2025
Download PDF
Read More
October 29, 2015
[…] control. Partly because of the vast numbers involved in the epidemic, which centered on Guinea, Sierra Leone, and Liberia, infectious disease experts say we are learning more every day about Ebola from cases […]
Your email address will not be published. Required fields are marked *
Δ
Which topic would you like to see ACEP Now tackle?
View Results
Loading ...
One Response to “Johnson & Johnson Begins Ebola Vaccine Trials in Sierra Leone”
October 29, 2015
Ebola's Persistence in Survivors Fuels Concerns Over Future Risks - ACEP Now[…] control. Partly because of the vast numbers involved in the epidemic, which centered on Guinea, Sierra Leone, and Liberia, infectious disease experts say we are learning more every day about Ebola from cases […]